Sleeve gastrectomy with transit bipartition

Sleeve gastrectomy with transit bipartition has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jan 28, 2026: “Efficacy and safety of single-anastomosis gastric bypass variants versus sleeve gastrectomy or Roux-en-Y gastric bypass: a systematic review…”.

Exposure

1 paper studies it2 findingsUpdated

See all 1 papers on sleeve gastrectomy with transit bipartition

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country

What did studies of sleeve gastrectomy with transit bipartition find?

2

Studies of sleeve gastrectomy with transit bipartition measured 2 outcomes: gastroesophageal reflux disease and weight loss.

Gastroesophageal reflux disease

downin humans1OR 6.9

1 study
  1. Sleeve gastrectomy with transit bipartition decreases gastroesophageal reflux disease in humans (OR = 6.90, CI 1.98–24.09).

    Review

More on Gastroesophageal reflux disease

Weight loss

upin humans1

1 study
  1. Sleeve gastrectomy with transit bipartition increases weight loss in humans (MD = 3.5%, CI 1.5–5.5%).

    Review1 year

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months